Accelerate Drug Discovery with Clinically Relevant Zebrafish Models

From Gene to Phenotype in a Vertebrate System

Custom zebrafish disease models for translational research.

Our Zebrafish Disease Model Construction Service provides end-to-end support for creating genetically defined models that recapitulate human disease pathology. Leveraging the genetic and physiological similarity between zebrafish and humans, we design and validate models for a wide range of indications, including metabolic, neurological, and cardiovascular disorders.

Zebrafish offer unique advantages for disease modeling: they share approximately 84% of disease-associated genes, develop externally, and produce hundreds of embryos per mating. Their transparency during early life stages enables non-invasive, real-time observation of disease progression and drug responses. These features make zebrafish an ideal platform for high-throughput, in vivo screening at a fraction of the cost of mammalian models.

We collaborate with you to define the disease hypothesis, select the appropriate genetic modification strategy (knockout, knock-in, or transgenic), and guide the model through construction, breeding, and phenotypic validation. Our service is designed to deliver a well-characterized, stable line that can be used immediately for efficacy testing or mechanistic studies.

Genetic Conservation Matters Zebrafish share about 84% of genes associated with human disease, providing strong biological relevance for modeling human conditions at the genetic and cellular levels.

Why Our Zebrafish Disease Models Accelerate Your Research

Three advantages that set our service apart.

Speed & Scalability

Rapid Model Generation

Due to external fertilization and high fecundity, stable transgenic or knockout lines can be generated in weeks rather than months. This allows you to iterate quickly on model design and move into screening phases without prolonged breeding timelines.

Translational Relevance

Genetic Similarity to Humans

With high conservation of disease-relevant genes and organ systems, zebrafish models can reproduce key human pathologies. This ensures that phenotypic readouts are meaningful for predicting drug efficacy and safety in clinical contexts.

Comprehensive Support

End-to-End Service

From guide RNA design and microinjection to phenotypic characterization and stable line expansion, we manage every step. You receive a fully documented model with genotyping data, imaging, and a summary of phenotype, ready for downstream applications.

Scientific Foundation of Zebrafish Disease Models

How we build human-relevant models from the ground up.

Genetic Homology

Zebrafish possess orthologs for more than 80% of human disease-associated genes. This high degree of conservation allows researchers to introduce patient-relevant mutations and observe comparable phenotypic outcomes.

Precision Genome Editing

We use precision genome editing with ribonucleoprotein complexes to create targeted insertions or deletions. Co-injection of genome editing enzymes and synthetic guide RNAs achieves high editing efficiency in one-cell embryos, enabling rapid generation of knockout and knock-in models.

External Development & Transparency

Fertilized embryos develop outside the mother and remain optically clear for several days. This permits direct visualization of organ development, fluorescent reporter expression, and disease-associated morphological changes without invasive procedures.

High-Throughput Potential

A single mating pair can produce 200–300 embryos, providing ample sample sizes for statistical power. This fecundity supports large-scale drug screening and dose-response studies within a single experimental cohort.

Disease Areas We Model

Proven model construction across major therapeutic areas.

♡

Metabolic Disorders

Obesity, NAFLD, type 2 diabetes, and dyslipidemia models using dietary induction or genetic modification.

▣

Neurodegenerative Diseases

Alzheimer's, Parkinson's, ALS, and Huntington's models with fluorescent reporters for aggregate visualization.

⬢

Cardiovascular Disease

Cardiomyopathy, arrhythmia, and vascular defects recapitulated through targeted gene knockout or morpholino knockdown.

◇

Muscular Dystrophy

Duchenne muscular dystrophy models showing muscle fiber degeneration and impaired locomotion.

◐

Oncology

Transgenic tumor models for angiogenesis, metastasis, and drug response studies using fluorescent labeling.

⚇

Inflammatory & Autoimmune Conditions

Zebrafish models of inflammatory bowel disease, psoriasis, and rheumatoid arthritis via chemical or genetic triggers.

Zebrafish vs. Traditional Models: A Side-by-Side Comparison

Understand the trade-offs for your specific research question.

Feature	Zebrafish	Mouse	Cell Line	Organoid
Genetic conservation to humans	~84% of disease genes shared	~90% orthologs	Human genome, but no systemic context	Human tissue-specific, limited to one organ
Throughput for screening	High — hundreds of embryos per assay	Low — cost and space limits sample sizes	Very high — 384-well plates	Medium — limited by manual culture
Time to generate stable line	Weeks to months	6–12 months	Weeks	Weeks to months
Cost per model	Low — minimal housing and husbandry	High — rodent facility and staffing	Low — media and plasticware	Medium — specialized media and matrices
Accessibility for real-time imaging	Transparent embryos enable non-invasive imaging	Requires invasive procedures or window chambers	Simple microscopy, but no whole-organism context	Visualizable but limited depth
Ethical consideration (3Rs)	Early stages not classified as animal experimentation	Requires ethical approval and justification	No ethical concerns	Minimal ethical oversight

Our Three-Step Model Construction Workflow

From concept to validated line in a streamlined process.

1

1. Target Gene Identification & Guide Design

We review your disease target and design genome editing guide RNAs with high on-target specificity. Synthetic guides are ordered and validated in vitro before injection. A detailed design report is provided for your approval.

In silico guide RNA design with off-target scoring.

→

2

2. Microinjection & Founder Screening

Genome editing enzymes and guide RNA are co-injected into one-cell zebrafish embryos. After development, we screen F0 founders for editing efficiency by PCR and sequencing. Positive founders are raised to adulthood for germline transmission.

Microinjection of genome editing reagents into zebrafish embryo at the one-cell stage.

→

3

3. Stable Line Expansion & Phenotypic Validation

F1 offspring from confirmed germline founders are genotyped and phenotyped. We assess morphological, behavioral, or molecular endpoints relevant to your disease model. A final report includes all genotyping data, images, and phenotype summary.

Comparison of wild-type and mutant larvae showing disease-relevant phenotype.

Bioinformatics & Data Analysis Support

From guide design to variant interpretation.

Customizable Analysis Pipeline

Target Sequence Retrieval — Retrieve zebrafish ortholog sequence for the human disease gene from Ensembl or NCBI. Confirm exon structure and conserved domains.
Genome Editing Guide Design & Off-Target Prediction — Design multiple guide RNAs targeting early exons or functional domains using algorithms trained on zebrafish genomes. Predict off-target sites using Bowtie or Cas-OFFinder.
Guide Efficiency Scoring — Score each guide for on-target activity using Doench/Fusi rules and rank by combined specificity and efficiency metrics.
Founder Screening Analysis — Analyze Sanger sequencing chromatograms from F0 fin clips to identify indels and determine editing efficiency using TIDE or ICE software.
Germline Transmission Verification — Confirm germline transmission by sequencing F1 larvae from outcrosses. Calculate germline transmission rate and allele diversity.

Design Report

Guide RNA Design & Off-Target Summary

List of 3–5 candidate guide RNAs with efficiency and specificity scores
Off-target sites predicted with genomic coordinates and mismatch number
Recommended guide and backup guides with justification

Validation Report

Stable Line Characterization Summary

F1 genotyping results with allele sequences and chromatogram traces
Germline transmission rate per founder
Phenotype description (morphological, behavioral, or molecular)
High-resolution images or videos of the phenotype

Applications of Custom Zebrafish Disease Models

How researchers use these models to advance therapeutic discovery.

1

High-Throughput Drug Screening

A zebrafish NAFLD model (induced by high-fat diet or genetic modification) can be used to screen libraries of compounds for lipid-lowering efficacy. Transparent larvae allow fluorescence-based readouts of lipid accumulation in real time, enabling dose-response analysis within days.

2

Mechanistic Studies of Genetic Variants

When a patient-specific mutation in a metabolic gene (e.g., PCSK9) is identified, a zebrafish knock-in model carrying the equivalent mutation is generated to study effects on LDL receptor recycling and plasma cholesterol levels.

3

Neurodegenerative Disease Phenotyping

Transgenic zebrafish expressing mutant huntingtin or alpha-synuclein show protein aggregation in the brain. These models are used to test small molecules that inhibit aggregation and to assess neuroprotective effects through locomotor assays.

4

Cardiotoxicity Assessment

Zebrafish models with engineered cardiac ion channel mutations (e.g., KCNQ1) recapitulate long QT syndrome. They are employed to evaluate proarrhythmic risk of drug candidates before mammalian studies.

Sample Submission Guidelines

Typical requirements for initiating a project.

Project Type	Material Provided	Amount	Turnaround
Genome Editing Knockout Line	Gene symbol or genomic coordinates; optional guide RNA sequence	Scoped per project	Confirmed with project plan
Knock-in (point mutation or reporter)	Donor template sequence (ssODN or plasmid)	Scoped per project	Confirmed with project plan
Morpholino Knockdown (transient model)	Target gene symbol; morpholino sequence can be designed by us	Scoped per project	Confirmed with project plan
Chemical Induction Model (e.g., HFD for NAFLD)	Specification of diet or compound, concentration, duration	Scoped per project	Confirmed with project plan

What You Receive

Deliverables for a standard knockout line project.

Stable F1 heterozygous or homozygous zebrafish line (minimum 10 adults, or as scoped)

Genotyping report with Sanger sequencing chromatograms and indel analysis

Phenotypic characterization report including morphological, behavioral, or molecular endpoints

High-resolution images and/or videos of the phenotype

Summary of germline transmission efficiency and allele inheritance pattern

Custom project report with methods, results, and quality control data

Frequently Asked Questions

Answers to common questions about our zebrafish disease model service.

How long does it take to generate a stable knockout zebrafish line?

The timeline depends on the complexity of the model and the time required to reach sexual maturity (approximately 3 months for F0 founders to produce F1 offspring). Typically, a stable line with confirmed germline transmission can be established within 4–6 months from project initiation. Exact timelines are defined during the scoping phase and depend on breeding success and screening requirements.

Can you model human diseases that do not have a zebrafish ortholog?

If there is no direct ortholog, alternative approaches such as transgenesis with the human gene (knock-in) or creation of a surrogate model using a related pathway can be considered. We will evaluate the feasibility during the consultation and propose the most appropriate strategy.

Do you provide drug screening services on the models you construct?

Yes, we can perform pharmacodynamic evaluation including efficacy and toxicity testing on your custom models. Our screening platform supports multi-dose, multi-endpoint readouts. This can be integrated into your project scope or conducted as a separate service.

What quality controls are performed to ensure the model is valid?

Each model undergoes rigorous QC: genotyping of at least 10 F1 offspring to confirm germline transmission, behavioral or morphological phenotyping, and comparison to wild-type controls. A detailed validation report is included in the deliverables.

What is the success rate of generating germline transmission?

Germline transmission rates vary by target and guide efficiency, but our optimized microinjection and founder screening protocols typically yield multiple independent lines. Specific rates are project-dependent and will be discussed during the proposal stage.